Skip to main content
. 2018 Dec 18;20(12):e11924. doi: 10.2196/11924

Table 4.

Summary of reasons for discontinuation.

Reason for discontinuation Trials (N=31), n (%)
Recruitment challenges 9 (29%)
Funding challenges 6 (19%)
New study priorities 3 (10%)
Primary investigator/staff attrition 2 (6%)
Drop out 2 (6%)
Technical challenges 2 (6%)
Primary investigator/staff attrition and funding challenges 2 (6%)
Not provided 5 (16%)